In agreement with this, middle-aged mice exhibit an increased susceptibility to the development of HFD-induced NAFLD, which is mediated by an increased abundance of CD36 on the plasma membrane. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.